Central arterial aging and the epidemic of systolic hypertension and atherosclerosis

Journal of the American Society of Hypertension

Volumn 1, Issue 5, 2007, Pages 302-340

  Lakatta, Edward G ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; arterial disease; arterial inflammation; arterial remodeling

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; CHEMOKINE RECEPTOR CCR2; CHOLESTEROL; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; LIPID; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ADULT; AGED; AGING; AORTA WALL; ARTERY COMPLIANCE; ARTERY DISEASE; ATHEROSCLEROSIS; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MODEL; EPIDEMIC; EXERCISE; FEMALE; FETUS CELL; HEREDITY; HUMAN; HYPERTENSION; HYPOTHESIS; INFLAMMATION; LIFESTYLE; LIFESTYLE MODIFICATION; LIPID METABOLISM; MALE; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PULSE WAVE; REVIEW; RISK FACTOR; RISK MANAGEMENT; SIGNAL TRANSDUCTION; SYSTOLE; VASCULAR ENDOTHELIUM; WEIGHT REDUCTION;

EID: 34648828570     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2007.05.001     Document Type: Review

References (223)

1. Najjar S.S., Scuteri A., and Lakatta E.G. Arterial aging: is it an immutable cardiovascular risk factor?. Hypertension 46 (2005) 454-462
2. Lakatta E.G., and Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set-up" for vascular disease. Circulation 107 (2003) 139-146
3. Najjar S.S., and Lakatta E.G. Vascular aging: from molecular to clinical cardiology. The Textbook of Molecular Cardiology (2002), Humana Press, Totowa, New Jersey 517-547
4. Wang M., and Lakatta E.G. Central arterial aging: humans to molecules. In: Safar M. (Ed). Handbook of Hypertension: Arterial Stiffness in Hypertension (2006), Elsevier 137-160
5. Gerstenblith G., Frederiksen J., Yin F.C., et al. Echocardiographic assessment of a normal adult aging population. Circulation 56 (1977) 273-278
6. Nagai Y., Metter E.J., Earley C.J., et al. Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation 98 (1998) 1504-1509
7. Vaitkevicius P.V., Fleg J.L., Engel J.H., et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 88 (1993) 1456-1462
8. Celermajer D.S., Sorensen K.E., Spiegelhalter D.J., et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24 (1994) 471-476
9. Lakatta E.G. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 73 (1993) 413-467
10. Virmani R., Avolio A.P., Mergner W.J., et al. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol 139 (1991) 1119-1129
11. Woo K.S., Chook P., Raitakari O.T., et al. Westernization of Chinese adults and increased subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 19 (1999) 2487-2493
12. Adams M.R., Nakagomi A., Keech A., et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation 92 (1995) 2127-2134
13. Li Z., Froehlich J., Galis Z.S., et al. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension 33 (1999) 116-123
14. Wang M., and Lakatta E.G. Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging. Hypertension 39 (2002) 865-873
15. Wang M., Takagi G., Asai K., et al. Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension 41 (2003) 1308-1316
16. Bode-Boger S.M., Muke J., Surdacki A., et al. Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med 8 (2003) 77-81
17. Wilkinson I.B., Franklin S.S., and Cockcroft J.R. Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 44 (2004) 112-116
18. Lakatta E.G. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part III: cellular and molecular clues to heart and arterial aging. Circulation 107 (2003) 490-497
19. Blacher J., Guerin A.P., Pannier B., et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99 (1999) 2434-2439
20. Kelly R., Hayward C., Avolio A., et al. Noninvasive determination of age-related changes in the human arterial pulse. Circulation 80 (1989) 1652-1659
21. Chen C.H., Nevo E., Fetics B., et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 95 (1997) 1827-1836
22. Lakatta E.G., and Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation 107 (2003) 346-354
23. McVeigh G.E., Bratteli C.W., Morgan D.J., Alinder C.M., Glasser S.P., Finkelstein S.M., et al. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance. Hypertension 33 (1999) 1392-1398
24. McVeigh G.E., Allen P.B., Morgan D.R., et al. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. Clin Sci (Lond) 100 (2001) 387-393
25. Mitchell G.F. Increased aortic stiffness: an unfavorable cardiorenal connection. Hypertension 43 (2004) 151-153
26. Safar M.E., London G.M., and Plante G.E. Arterial stiffness and kidney function. Hypertension 43 (2004) 163-168
27. O'Rourke M.F. Arterial Function in Health and Disease (1982), Churchill Livingstone, New York, New York 275
28. O'Rourke M.F. Vascular impedance in studies of arterial and cardiac function. Physiol Rev 62 (1982) 570-623
29. Nichols W.W., O'Rourke M.F., Avolio A.P., et al. Effects of age on ventricular-vascular coupling. Am J Cardiol 55 (1985) 1179-1184
30. Nichols W.W., O'Rourke M.F., Avolio A.P., et al. Age-related changes in left ventricular/arterial coupling. In: Yin F.C.P. (Ed). Ventricular Vascular Coupling: Clinical Physiology, and Engineering Aspects (1987), Springer-Verlag, New York, New York 79-114
31. Carroll J.D., Shroff S., Wirth P., et al. Arterial mechanical properties in dilated cardiomyopathy: aging and the response to nitroprusside. J Clin Invest 87 (1991) 1002-1009
32. Fleg J.L., Gerstenblith G., Schulman S.P., et al. Gender differences in exercise hemodynamics of older subjects: effects of conditioning status. Circulation 82 (1990) (abstract) III-239
33. Nichols W.W., O'Rourke M.F., Avolio A.P., et al. Ventricular/vascular interaction in patients with mild systemic hypertension and normal peripheral resistance. Circulation 74 (1986) 455-462
34. Rodeheffer R.J., Gerstenblith G., Becker L.C., et al. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation 69 (1984) 203-213
35. Peterson L.H., Jensen R.E., and Parnell J. Mechanical properties of arteries in vivo. Circ Res 8 (1960) 622-639
36. Remington J.W. The physiology of the aorta and major arteries. Handbook of Physiology. Circulation (1963), American Physiology Society, Washington, DC 808
37. Safar M.E., Toto-Moukouo J.J., Bouthier J.A., et al. Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment. Circulation 75 suppl I (1987) I156-I161
38. Simon A.C., Levenson J.A., Bouthier J.L., et al. Captopril-induced changes in large arteries in essential hypertension. Am J Med 76 (1984) 71-75
39. Ting C.T., Brin K.P., Lin S.J., Wang S.P., et al. Arterial hemodynamics in human hypertension. J Clin Invest 78 (1986) 1462-1471
40. Murgo J.P., Westerhof N., Giolma J.P., and Altobelli S.A. Effects of exercise on aortic input impedance and pressure wave forms in normal humans. Circ Res 48 (1981) 334-343
41. Yin F.C.P., Weisfeldt M.L., and Milnor W.R. Role of aortic input impedance in the decreased cardiovascular response to exercise with aging in dogs. J Clin Invest 68 (1981) 28-38
42. Yin F.C.P., Spurgeon H.A., and Kallman C.H. Age-associated alterations in viscoelastic properties of canine aortic strips. Circ Res 53 (1983) 464-472
43. Elzinga G., and Westerhof N. Pressure and flow generated by the left ventricle against different impedances. Circ Res 32 (1973) 178-186
44. Nichols W.W., and Pepine C.J. Left ventricular afterload and aortic input impedance: implications of pulsatile bold flow. Prog Cardiovasc Dis 24 (1982) 293-306
45. Nichols W.W., Pepine C.J., Feldman R.L., et al. Influence of changes in pulsatile components of vascular load on left ventricular function: power-load relations in patients without heart failure. Circulation 60 (1979) (abstract) II-94
46. Sunagawa K., Maughan W.L., and Sagawa K. Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res 56 (1985) 586-595
47. Olivetti G., Melissari M., Capasso J.M., et al. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 68 (1991) 1560-1568
48. Unverferth D.V., Fetters J.K., Unverferth B.J., et al. Human myocardial histologic characteristics in congestive heart failure. Circulation 68 (1983) 1194-1200
49. Gardin J.M., Henry W.L., Savage D.D., et al. Echocardiographic measurements in normal subjects: evaluation of an adult population without clinically apparent heart disease. J Clin Ultrasound 7 (1979) 439-447
50. Sjogren A.L. Left ventricular wall thickens determined by ultrasound in 100 subjects without heart disease. Chest 60 (1971) 341-346
51. Isnard R.N., Pannier B.M., Laurent S., et al. Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: a noninvasive study. J Am Coll Cardiol 13 (1989) 399-405
52. Fleg J.L., O'Connor F., Gerstenblith G., et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol 78 (1995) 890-900
53. Najjar S.S., Schulman S.P., Gerstenblith G., et al. Age and gender affect ventricular-vascular coupling during aerobic exercise. J Am Coll Cardiol 144 (2004) 611-617
54. Arnett D.K., Tyroler H.A., Burke G., et al. Hypertension and subclinical carotid artery atherosclerosis in blacks and whites: the Atherosclerosis Risk in Communities Study. ARIC Investigators. Arch Intern Med 156 (1996) 1983-1989
55. Nichols W.W., Nicolini F.A., and Pepine C.J. Determinants of isolated systolic hypertension in the elderly. J Hypertens Suppl 10 (1992) S73-S77
56. Laurent S., Lacolley P., Girerd X., et al. Arterial stiffening: opposing effects of age- and hypertension-associated structural changes. Can J Physiol Pharmacol 74 (1996) 842-849
57. O'Rourke M.F., and Nichols W.W. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension 45 (2005) 652-658
58. Mitchell G.F., Lacourciere Y., Ouellet J.P., et al. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation 108 (2003) 1592-1598
59. Chobanian A.V., Bakris G.L., Black H.R., et al., Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
60. Giles T.D., Berk B.C., Black H.R., et al. Expanding the definition and classification of hypertension (Greenwich). J Clin Hypertens 7 (2005) 505-512
61. Perticone F., Ceravolo R., Pujia A., et al. Prognostic significance of endolethial dysfunction in hypertensive patients. Circulation 104 (2001) 191-196
62. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
63. Taddei S., Virdis A., Mattei P., et al. Hypertension causes premature aging of endothelial function in humans. Hypertension 29 (1997) 736-743
64. Taddei S., Virdis A., Mattei P., et al. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 94 (1996) 1298-1303
65. Benetos A., Okuda K., Lajemi M., et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 37 (2001) 381-385
66. Kannel W.B. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 85 (2000) 251-255
67. Sesso H.D., Stampfer M.J., Rosner B., et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension 36 (2000) 801-807
68. Neutel J.M. Beyond the sphygmomanometric numbers: hypertension as a syndrome. Am J Hypertens 14 (2001) 250S-257S
69. Liao D., Arnett D.K., Tyroler H.A., et al. Arterial stiffness and the development of hypertension: the ARIC Study. Hypertension 34 (1999) 201-206
70. Blacher J., Pannier B., Guerin A.P., et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32 (1998) 570-574
71. Boutouyrie P., Tropeano A.I., Asmar R., et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a Longitudinal Study. Hypertension 39 (2002) 10-15
72. Willum-Hansen T., Staessen J.A., Torp-Pedersen C., et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113 (2006) 664-670
73. Mattace-Raso F.U., van der Cammen T.J., Knetsch A.M., et al. Arterial stiffness as the candidate underlying mechanism for postural blood pressure changes and orthostatic hypotension in older adults: the Rotterdam Study. J Hypertens 24 (2006) 339-344
74. Sutton-Tyrrell K., Najjar S.S., Boudreau R.M., et al., Health ABC Study. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 111 (2005) 3384-3390
75. de Simone G., Roman M.J., Koren M.J., et al. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension. Hypertension 33 (1999) 800-805
76. Blacher J., Asmar R., Djane S., et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33 (1999) 1111-1117
77. Guerin A.P., Blacher J., Pannier B., et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103 (2001) 987-992
78. London G.M., Blacher J., Pannier B., et al. Arterial wave reflections and survival in end-stage renal failure. Hypertension 38 (2001) 434-438
79. Scuteri A., Chen C.H., Yin F.C., et al. Functional correlates of central arterial geometric phenotypes. Hypertension 38 (2001) 1471-1475
80. Scuteri A., Manolio T.A., Marino E.K., et al. Prevalence of specific variant carotid geometric patterns and incidence of cardiovascular events in older persons: the Cardiovascular Health Study (CHS E-131). J Am Coll Cardiol 43 (2004) 187-193
81. Graner M., Varpula M., Kahri J., et al. Association of carotid intima-media thickness with angiographic severity and extent of coronary artery disease. Am J Cardiol 97 (2006) 624-629
82. van Popele N.M., Grobbee D.E., Bots M.L., et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 32 (2001) 454-460
83. Weber T., Auer J., O'Rourke M.F., et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 109 (2004) 184-189
84. Samani N.J., Boultby R., Butler R., et al. Telomere shortening in atherosclerosis. Lancet 358 (2001) 472-473
85. Aminbakhsh A., and Mancini G.B. Carotid intima-media thickness measurements: what defines an abnormality?. A systematic review. Clin Invest Med 22 (1999) 149-157
86. Chambless L.E., Folsom A.R., Clegg L.X., et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 151 (2000) 478-487
87. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study collaborative research group. N Engl J Med 340 (1999) 14-22
88. Scuteri A., Najjar S.S., Muller D.C., et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 43 (2004) 1388-1395
89. Sutton-Tyrrell K., Newman A., Simonsick E.M., et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 38 (2001) 429-433
90. Mackey R.H., Sutton-Tyrrell K., Vaitkevicius P.V., et al. Correlates of aortic stiffness in elderly individuals: a subgroup of the Cardiovascular Health Study. Am J Hypertens 15 (2002) 16-23
91. Salomaa V., Riley W., Kark J.D., et al. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 91 (1995) 1432-1443
92. Wagenknecht L.E., Zaccaro D., Espeland M.A., et al. Diabetes and progression of carotid atherosclerosis: the Insulin Resistance Atherosclerosis Study. Arterioscler Thromb Vasc Biol 23 (2003) 1035-1041
93. Schofield I., Malik R., Izzard A., et al. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 106 (2002) 3037-3043
94. Balletshofer B.M., Rittig K., Enderle M.D., et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101 (2000) 1780-1784
95. Jeanclos E., Krolewski A., Skurnick J., et al. Shortened telomere length in white blood cells of patients with IDDM. Diabetes 47 (1998) 482-486
96. Brownlee M., Cerami A., and Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318 (1988) 1315-1321
97. Amar J., Ruidavets J.B., Chamontin B., et al. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 19 (2001) 381-387
98. McVeigh G., Brennan G., Hayes R., Cohn J., Finkelstein S., and Johnston D. Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis. Am J Med 95 (1993) 424-430
99. Wolinsky H., and Glagov S. Structural basis for the static mechanical properties of the aortic media. Circ Res 14 (1964) 400-413
100. Wolinsky H., and Glagov S. A lamellar unit of aortic medial structure and function in mammals. Circ Res 20 (1967) 99-111
101. Wolinsky H., and Glagov S. Comparison of abdominal and thoracic aortic medial structure in mammals: deviation of man from the usual pattern. Circ Res 25 (1969) 677-686
102. Dontas A.S., Taylor H.C., and Keys A. Carotid pressure plethysmograms: effects of age, diastolic pressure, relative body weight, and physical activity. Arch Kreisluufforsch 36 (1961) 49-58
103. Freis E.D., Heath W.C., Luchsinger P.C., and Snell R.E. Changes in the carotid pulse which occur with age and hypertension. Am Heart J 71 (1966) 757-765
104. Haynes F.W., Ellis L.B., and Weiss S. Pulse wave velocity and arterial elasticity in arterial hypertension, arteriosclerosis, and related conditions. Am Heart J 11 (1936) 385-401
105. Lansing A.I. The Arterial Wall: Aging, Structure, and Chemistry (1959), Williams & Wilkins, Baltimore, Maryland 136-160
106. Nakashima T., and Tanikawa J. A study of human aortic distensibility with relations to atherosclerosis and aging. Angiology 22 (1971) 477-490
107. Orlandi A., Mauriello A., Marino B., et al. Age-related modifications of aorta and coronaries in the rabbit: a morphological and morphometrical assessment. Arch Gerontol Geriatr 17 (1993) 37-53
108. Kaplan D., and Meyer K. Mucopolysaccharides of aorta at various ages. Proc Sot Exp Biol Med 105 (1960) 78-81
109. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 21 (2003) 3-12
110. Yan S.F., Ramasamy R., Naka Y., et al. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93 (2003) 1159-1169
111. Cantini C., Kieffer P., Corman B., et al. Aminoguanidine and aortic wall mechanics, structure, and composition in aged rats. Hypertension 38 (2001) 943-948
112. Vaitkevicius P.V., Lane M., Spurgeon H., et al. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci U S A 98 (2001) 1171-1175
113. Wolffenbuttel B.H., Boulanger C.M., Crijns F.R., et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A 95 (1998) 4630-4634
114. Kass D.A., Shapiro E.P., Kawaguchi M., et al. Improved arterial compliance by a novel advanced glycation end-product cross-link breaker. Circulation 104 (2004) 1464-1470
115. Chen J., Bridsky S.V., Goligorsky D.M., et al. Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res 90 (2002) 1290-1298
116. Li J.H., Huang X.R., Zhu H.J., et al. Advanced glycation end products activate SMAD signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB J 18 (2004) 176-178
117. Basta G., Schmidt A.M., and De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63 (2004) 582-592
118. Ichii T., Koyama H., Tanaka S., et al. Fibrillar collagen specifically regulates human vascular smooth muscle cell genes involved in cellular responses and the pericellular matrix environment. Circ Res 88 (2001) 460-467
119. Price P.A., June H.H., Buckley J.R., et al. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21 (2001) 1610-1616
120. Parhami F., and Demer L.L. Arterial calcification in face of osteoporosis in aging: can we blame oxidized lipids?. Curr Opin Lipidol 8 (1997) 312-314
121. Rutsch F., and Terkeltaub R. Parallels between arterial and cartilage calcification: what understanding artery calcification can teach us about chondrocalcinosis. Curr Opin Rheumatol 15 (2003) 302-310
122. Roach M.R., and Burton A.C. The effect of age on the elasticity of human iliac arteries. Can J Biochem Physiol 37 (1959) 557-570
123. Faber M., and Moller-Hou G. The human aorta. V. Collagen and elastin in the normal and hypertensive aorta. Acta Pathol Microbial Scand 31 (1952) 377-382
124. Harding S.E., Jones S.M., O'Gara P., et al. Isolated ventricular myocytes from failing and nonfailing human heart: the relation of age and clinical status of patients to isoproterenol response. J Mol Cell Cardiol 24 (1992) 549-564
125. King A.L. Pressure-volume relation for cylindrical tubes with elastomeric walls: the human aorta. J Appl Physics 17 (1946) 501-505
126. Dempsey E.W., and Lansing A. 1. Elastic tissue. Intern Rev Cytol 3 (1954) 437-453
127. Robert L., Robert B., and Robert A.M. Molecular biology of elastin as related to aging and atherosclerosis. Exp Gerontol 5 (1970) 339-356
128. Wolinsky H. Long-term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes. Morphological and chemical studies. Circ Res 30 (1972) 301-309
129. Seligman M., Eilberg R.F., and Fishman L. Mineralization of elastin extracted from human aortic tissues. Calcif Tissue Res 17 (1975) 229-234
130. Labat-Robert J. Cell-matrix interactions in aging: role of receptors and matricryptins. Aging Res Rev 3 (2004) 233-247
131. Teti A. Regulation of cellular functions by extracellular matrix. J Am Soc Nephrol 2 (1992) S83-S87
132. Wachi H., Seyama Y., Yamashita S., et al. Enhanced tropoelastin-degrading activity during cell passages in cultured smooth muscle cells. Biochim Biophys Acta 1243 (1995) 393-398
133. Foster J.A., Rich C.B., Miller M., et al. Effect of age and IGF-I administration on elastin gene expression in rat aorta. J Gerontol 45 (1990) B113-B118
134. Kielty C.M., Sherratt M.J., and Shuttleworth C.A. Elastic fibres. J Cell Sci 115 (2002) 2817-2828
135. Chesler N.C., Ku D.N., and Galis Z.S. Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo. Am J Physiol 277 (1999) H2002-H2009
136. Li Z., Cheng H., Lederer W.J., et al. Enhanced proliferation and migration and altered cytoskeletal proteins in early passage smooth muscle cells from young and old rat aortic explants. Exp Mol Pathol 64 (1997) 1-11
137. Gennaro G., Menard C., Giasson E., et al. Role of p44/p42 MAP kinase in the age-dependent increase in vascular smooth muscle cell proliferation and neointimal formation. Arterioscler Thromb Vasc Biol 23 (2003) 204-210
138. Rivard A., Principe N., and Andres V. Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells. A potential link between aging, smooth muscle cell proliferation and atherosclerosis. Cardiovasc Res 45 (2000) 1026-1034
139. Yoshida Y., Mitsumata M., Ling G., et al. Migration of medial smooth muscle cells to the intima after balloon injury. Ann NY Acad Sci 811 (1997) 459-470
140. Pauly R.R., Passaniti A., Crow M., et al. Experimental models that mimic the differentiation and dedifferentiation of vascular cells. Circulation 86 (1992) III68-III73
141. Spinetti G., Wang M., Monticone R., et al. Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function. Arterioscler Thromb Vasc Biol 24 (2004) 1397-1402
142. Motwani J.G., and Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97 (1998) 916-931
143. Wang M., Zhang J., Jiang L.-Q., et al. A Proinflammatory profile within the grossly normal human aortic wall accompanies advancing age. Hypertension 50 (2007) 219-227
144. Asai K., Kudej R.K., Shen Y.T., et al. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol 20 (2000) 1493-1499
145. Shi Q., Aida K., Vandeberg J.L., et al. Passage-dependent changes in baboon endothelial cells-relevance to in vitro aging. DNA Cell Biol 23 (2004) 502-509
146. Wagner M., Hampel B., Bernhard D., et al. Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp Gerontol 36 (2001) 1327-1347
147. Niu S., and Matsuda T. Endothelial cell senescence inhibits unidirectional endothelialization in vitro. Cell Transplant 1 (1992) 355-364
148. Yeh H.I., Chang H.M., Lu W.W., et al. Age-related alteration of gap junction distribution and connexin expression in rat aortic endothelium. J Histochem Cytochem 48 (2000) 1377-1389
149. Chang E., and Harley C.B. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci U S A 92 (1995) 11190-11194
150. Iwama H., Ohyashiki K., Ohyashiki J.H., et al. Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum Genet 102 (1998) 397-402
151. Orlandi A., Marcellini M., and Spagnoli L.G. Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 20 (2000) 1123-1136
152. Morisaki N., Saito I., Tamura K., et al. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis 131 (1997) 43-48
153. Comi P., Chiaramonte R., and Maier J.A. Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells. Exp Cell Res 219 (1995) 304-308
154. Belmin J., Corman B., Merval R., et al. Age-related changes in endothelial permeability and distribution volume of albumin in rat aorta. Am J Physiol 264 (1993) H679-H685
155. Matz R.L., and Andriantsitohaina R. Age-related endothelial dysfunction: potential implications for pharmacotherapy. Drugs Aging 20 (2003) 527-550
156. Cernadas M.R., Sanchez de Miguel L., Garcia-Duran M., et al. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res 83 (1998) 279-286
157. Chou T.C., Yen M.H., Li C.Y., et al. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 31 (1998) 643-648
158. Berkowitz D.E., White R., Li D., et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108 (2003) 2000-2006
159. Van der Loo B., Labugger R., Skepper J.N., et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 192 (2000) 1731-1743
160. Hamilton C.A., Brosnan M.J., McIntyre M., et al. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 37 (2001) 529-534
161. Mollnau H., Wendt M., Szocs K., et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90 (2002) E58-E65
162. Csiszar A., Ungvari Z., Edwards J.G., et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 90 (2002) 1159-1166
163. Sun D., Huang A., Yan E.H., et al. Reduced release of nitric oxide to shear stress in mesenteric arteries of aged rats. Am J Physiol Heart Circ Physiol 286 (2004) H2249-H2256
164. Wendt T., Bucciarelli L., Qu W., et al. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Curr Atheroscler Rep 4 (2002) 228-237
165. Pauly R.R., Passaniti A., Bilato C., et al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 75 (1994) 41-54
166. Cheng L., Mantile G., Pauly R., et al. Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation 98 (1998) 2195-2201
167. McNulty M., Spier J.P., McGoven E., et al. Aging is associated with increased MMP-2 activity in the human aorta. Am J Hypertens 18 (2005) 504-509
168. Bilato C., and Crow M.T. Atherosclerosis and the vascular biology of aging (Milano). Aging 8 (1996) 221-234
169. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104 (2001) 365-372
170. Daugherty A., and Cassis L. Angiotensin II-mediated development of vascular diseases. Trends Cardiovasc Med 14 (2004) 117-120
171. Hosomi N., Noma T., Ohyama H., et al. Vascular proliferation and transforming growth factorbeta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. Atherosclerosis 162 (2002) 69-76
172. Carrieri G., Marzi E., Olivieri F., et al. The G/C915 polymorphism of transforming growth factor beta1 is associated with human longevity: a study in Italian centenarians. Aging Cell 3 (2004) 443-448
173. Lawrence D.A. Latent-TGF-beta: an overview. Mol Cell Biochem 219 (2001) 163-170
174. Karsdal M.A., Larsen L., Engsig M.T., et al. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem 277 (2002) 44061-44067
175. Wang M., Zhang J., Spinetti G., et al. Angiotensin II activates matrix metalloproteinase type II and mimics age associated carotid arterial remodeling in young rats. Am J Pathol 167 (2005) 1429-1442
176. Wahl S.M. Transforming growth factor-beta (TGF-beta) in inflammation: a cause and a cure. J Clin Immunol 12 (1992) 61-74
177. McCaffrey T.A., Du B., Consigli S., et al. Genomic instability in the type TGF-β1 receptor gene in atherosclerosis and restenotic vascular cells. J Clin Invest 100 (1997) 2182-2188
178. Shull M.M., Ormsby I., Kier A.B., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359 (1992) 693-699
179. Huynh M.L., Fadok V.A., and Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109 (2002) 41-50
180. McCaffrey T.A. TGF-betas and TGF-beta receptors in atherosclerosis. Cytokine Growth Factor Rev 11 (2000) 103-114
181. McCaffrey T.A., and Falcone D.J. Evidence for an age-associated
182. Li X., and Eriksson U. Novel PDGF family members: PDGF-C and PDGF-D. Cytokine Growth Factor Rev 14 (2003) 91-98
183. Sarzani R., Arnaldi G., Takasaki I., et al. Effects of hypertension and aging on platelet-derived growth factor and platelet-derived growth factor receptor expression in rat aorta and heart. Hypertension 18 (1991) III93-III99
184. Inadera H., Egashira K., Takemoto M., et al. Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Interferon Cytokine Res 19 (1999) 1179-1182
185. Bursill C.A., Channon K.M., and Greaves D.R. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics. Curr Opin Lipidol 15 (2004) 145-149
186. Visser M., Pahor M., Taaffe D.R., et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57 (2002) M326-M332
187. Csiszar A., Ungvari Z., Koller A., et al. Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB J 17 (2003) 1183-1185
188. Csiszar A., Ungvari Z., Koller A., et al. Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. Physiol Genomics 17 (2004) 21-30
189. Safar M.E., and Benetos A. Factors influencing arterial stiffness in systolic hypertension in the elderly: role of sodium and the renin-angiotensin system. Am J Hypertens 16 (2003) 249-258
190. Eggena P., Morin A.M., Barrett J.D., et al. The influence of aging on angiotensinogen production by rat vascular smooth muscle cells in vitro. Clin Exp Hypertens A 10 (1988) 597-603
191. Challah M., Nadaud S., Philippe M., et al. Circulating and cellular markers of endothelial dysfunction with aging in rats. Am J Physiol 273 (1997) H1941-H1948
192. Touyz R.M., Endemann D., He G., et al. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 33 (1999) 366-372
193. Matrougui K., Loufrani L., Heymes C., et al. Activation of AT(2) receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension 34 (1999) 659-665
194. Usui M., Egashira K., Tomita H., et al. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. Circulation 101 (2000) 305-310
195. Wang M., Zhao D., Spinetti G., et al. Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall. Arterioscler Thromb Vasc Biol 26 (2006) 1503-1509
196. Ishibashi M., Hiasa K., Zhao Q., et al. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ Res 94 (2004) 1203-1210
197. Farmer J.A., and Torre-Amione G. The rennin-angiotensin system as a risk factor for coronary artery disease. Curr Atheroscler Rep 3 (2001) 117-124
198. Mavri A., Stegnar M., Sentocnik J.T., et al. Impact of weight reduction on early carotid atherosclerosis in obese premenopausal women. Obes Res 9 (2001) 511-516
199. Wildman R.P., Schott L.L., Brockwell S., et al. A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries. J Am Coll Cardiol 44 (2004) 579-585
200. Fontana L., Meyer T.E., Klein S., et al. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A 101 (2004) 6659-6663
201. Tanaka H., and Safar M.E. Influence of lifestyle modification on arterial stiffness and wave reflections. Am J Hypertens 18 (2005) 137-144
202. Avolio A.P., Clyde K.M., Beard T.C., et al. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis 6 (1986) 166-169
203. Hambrecht R., Wolf A., Gielen S., et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 342 (2000) 454-460
204. Hamdy O., Ledbury S., Mullooly C., et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 26 (2003) 2119-2125
205. Raitakari M., Ilvonen T., Ahotupa M., et al. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol 24 (2004) 124-128
206. Rywik T.M., Blackman R., Yataco A.R., et al. Enhanced endothelial vasoreactivity in endurance trained older men. J Appl Physiol 87 (1999) 2136-2142
207. Huang W., Alhenc Gelas F., and Osborne-Pellegrin M.J. Protection of the arterial internal elastic lamina by inhibition of the rennin-angiotensin system in the rat. Circ Res 82 (1998) 879-890
208. Michel J.B., Heudes D., Michel O., et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol 267 (1994) R124-R135
209. Levy B.I., Michel J.B., Salzmann J.L., et al. Remodeling of heart and arteries by chronic converting enzyme inhibition in spontaneously hypertensive rats. Am J Hypertens 4 (1991) 240S-245S
210. Gonzalez Bosc L.V., Kurnjek M.L., Muller A., et al. Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging. J Hypertens 19 (2001) 1403-1409
211. Moon S.K., Thompson L.J., Madamanchi N., et al. Aging, oxidative responses, and proliferative capacity in cultured mouse aortic smooth muscle cells. Am J Physiol Heart Circ Physiol 280 (2001) H2779-H2788
212. de Cavanagh E.M., Fraga C.G., Ferder L., et al. Enalapril and captopril enhance antioxidant defenses in mouse tissues. Am J Physiol 272 (1997) R514-R518
213. Inserra F., Romano L., Ercole L., et al. Cardiovascular changes by long-term inhibition of the renin-angiotensin system in aging. Hypertension 25 (1995) 437-442
214. Ferder L., Romano L.A., Ercole L., et al. Biomolecular changes in the aging myocardium: the effect of enalapril. Am J Hypertens 11 (1998) 1297-1304
215. Ferder L.F., Inserra F., and Basso N. Advances in our understanding of aging: role of the renin-angiotensin system (review). Curr Opin Pharmacol 2 (2002) 189-194
216. Alder A., Messina E., Sherman B., et al. NAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O2 consumption by NO in old Fischer 344 rats. Am J Physiol Heart Circ Physiol 285 (2003) H1015-H1022
217. Joffres M.R., Hamet P., and MacLean D.R. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 14 (2001) 1099-1105
218. Wolf P.A., and Lewis A. Conner lecture. Contributions of epidemiology to the prevention of stroke. Circulation 88 (1993) 2471-2478
219. Arnold A.M., Psaty B.M., Kuller L.H., et al. Redrawn from incidence of cardiovascular disease in older Americans: the Cardiovascular Health Study. J Am Geriatr Soc 53 (2005) 211-218
220. Ho K.K., Pinsky J.L., Kannel W.B., et al. The epidemiology of heart failure: the Framingham Heart Study. J Am Coll Cardiol 22 (1993) 6A-13A
221. Pearson J.D., Morrell C.H., Brant L.J., et al. Age-associated changes in blood pressure in a longitudinal study of healthy men and women. J Gerontol Med Sci 52 (1997) M177-M183
222. Mattace-Raso F.U., van der Cammen T.J., Hofman A., et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113 (2006) 657-663
223. Tanaka H., DeSouza C.A., and Seals D.R. From absence of age-related increase in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol 18 (1998) 127-132